201 related articles for article (PubMed ID: 28964572)
1. Transcription factor MafB may play an important role in secondary hyperparathyroidism.
Morito N; Yoh K; Usui T; Oishi H; Ojima M; Fujita A; Koshida R; Shawki HH; Hamada M; Muratani M; Yamagata K; Takahashi S
Kidney Int; 2018 Jan; 93(1):54-68. PubMed ID: 28964572
[TBL] [Abstract][Full Text] [Related]
2. MafB interacts with Gcm2 and regulates parathyroid hormone expression and parathyroid development.
Kamitani-Kawamoto A; Hamada M; Moriguchi T; Miyai M; Saji F; Hatamura I; Nishikawa K; Takayanagi H; Hitoshi S; Ikenaka K; Hosoya T; Hotta Y; Takahashi S; Kataoka K
J Bone Miner Res; 2011 Oct; 26(10):2463-72. PubMed ID: 21713993
[TBL] [Abstract][Full Text] [Related]
3. Gata3 cooperates with Gcm2 and MafB to activate parathyroid hormone gene expression by interacting with SP1.
Han SI; Tsunekage Y; Kataoka K
Mol Cell Endocrinol; 2015 Aug; 411():113-20. PubMed ID: 25917456
[TBL] [Abstract][Full Text] [Related]
4. Micro-RNAs in the parathyroid: a new portal in understanding secondary hyperparathyroidism.
Shilo V; Silver J; Naveh-Many T
Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):271-7. PubMed ID: 27138227
[TBL] [Abstract][Full Text] [Related]
5. Autoregulation in the parathyroid glands by PTH/PTHrP receptor ligands in normal and uremic rats.
Lewin E; Garfia B; Almaden Y; Rodriguez M; Olgaard K
Kidney Int; 2003 Jul; 64(1):63-70. PubMed ID: 12787396
[TBL] [Abstract][Full Text] [Related]
6. The influence of the progression of secondary hyperparathyroidism on the set point of the parathyroid hormone-calcium curve.
Bas S; Aguilera-Tejero E; Bas A; Estepa JC; Lopez I; Madueño JA; Rodriguez M
J Endocrinol; 2005 Jan; 184(1):241-7. PubMed ID: 15642800
[TBL] [Abstract][Full Text] [Related]
7. Post-transcriptional mechanisms regulating parathyroid hormone gene expression in secondary hyperparathyroidism.
Kilav-Levin R; Hassan A; Nechama M; Shilo V; Silver J; Ben-Dov IZ; Naveh-Many T
FEBS J; 2020 Jul; 287(14):2903-2913. PubMed ID: 32191397
[TBL] [Abstract][Full Text] [Related]
8. Effects of FGF-23-mediated ERK/MAPK signaling pathway on parathyroid hormone secretion of parathyroid cells in rats with secondary hyperparathyroidism.
Chen XJ; Chen X; Wu WJ; Zhou Q; Gong XH; Shi BM
J Cell Physiol; 2018 Sep; 233(9):7092-7102. PubMed ID: 29633272
[TBL] [Abstract][Full Text] [Related]
9. Relationship between parathyroid calcium-sensing receptor expression and potency of the calcimimetic, cinacalcet, in suppressing parathyroid hormone secretion in an in vivo murine model of primary hyperparathyroidism.
Kawata T; Imanishi Y; Kobayashi K; Kenko T; Wada M; Ishimura E; Miki T; Nagano N; Inaba M; Arnold A; Nishizawa Y
Eur J Endocrinol; 2005 Oct; 153(4):587-94. PubMed ID: 16189180
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid-specific deletion of dicer-dependent microRNAs abrogates the response of the parathyroid to acute and chronic hypocalcemia and uremia.
Shilo V; Ben-Dov IZ; Nechama M; Silver J; Naveh-Many T
FASEB J; 2015 Sep; 29(9):3964-76. PubMed ID: 26054367
[TBL] [Abstract][Full Text] [Related]
11. PTHrP enhances the secretory response of PTH to a hypocalcemic stimulus in rat parathyroid glands.
Lewin E; Almaden Y; Rodriguez M; Olgaard K
Kidney Int; 2000 Jul; 58(1):71-81. PubMed ID: 10886551
[TBL] [Abstract][Full Text] [Related]
12. Increased parathyroid expression of klotho in uremic rats.
Hofman-Bang J; Martuseviciene G; Santini MA; Olgaard K; Lewin E
Kidney Int; 2010 Dec; 78(11):1119-27. PubMed ID: 20631679
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid-specific epidermal growth factor-receptor inactivation prevents uremia-induced parathyroid hyperplasia in mice.
Arcidiacono MV; Yang J; Fernandez E; Dusso A
Nephrol Dial Transplant; 2015 Mar; 30(3):434-40. PubMed ID: 25324357
[TBL] [Abstract][Full Text] [Related]
14. Persistent fibroblast growth factor 23 signalling in the parathyroid glands for secondary hyperparathyroidism in mice with chronic kidney disease.
Kawakami K; Takeshita A; Furushima K; Miyajima M; Hatamura I; Kuro-O M; Furuta Y; Sakaguchi K
Sci Rep; 2017 Jan; 7():40534. PubMed ID: 28094278
[TBL] [Abstract][Full Text] [Related]
15. Regulation of PTH mRNA stability by the calcimimetic R568 and the phosphorus binder lanthanum carbonate in CKD.
Nechama M; Ben-Dov IZ; Silver J; Naveh-Many T
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F795-800. PubMed ID: 19129257
[TBL] [Abstract][Full Text] [Related]
16.
Shilo V; Mor-Yosef Levi I; Abel R; Mihailović A; Wasserman G; Naveh-Many T; Ben-Dov IZ
J Am Soc Nephrol; 2017 Aug; 28(8):2353-2363. PubMed ID: 28298326
[TBL] [Abstract][Full Text] [Related]
17. Regulation of parathyroid function in chronic kidney disease (CKD).
Fukagawa M; Nakanishi S; Fujii H; Hamada Y; Abe T
Clin Exp Nephrol; 2006 Sep; 10(3):175-9. PubMed ID: 17009074
[TBL] [Abstract][Full Text] [Related]
18. The peptidyl-prolyl isomerase Pin1 determines parathyroid hormone mRNA levels and stability in rat models of secondary hyperparathyroidism.
Nechama M; Uchida T; Mor Yosef-Levi I; Silver J; Naveh-Many T
J Clin Invest; 2009 Oct; 119(10):3102-14. PubMed ID: 19770516
[TBL] [Abstract][Full Text] [Related]
19. Sevelamer hydrochloride suppresses proliferation of parathyroid cells during the early phase of chronic renal failure in rats.
Xiao X; Liu Y; Zhong X; Liu Y; Zhou D; Xiong X; Ran J
Nephrology (Carlton); 2019 Jan; 24(1):127-133. PubMed ID: 29278442
[TBL] [Abstract][Full Text] [Related]
20. Does the downregulation of the FGF23 signaling pathway in hyperplastic parathyroid glands contribute to refractory secondary hyperparathyroidism in CKD patients?
Lafage-Proust MH
Kidney Int; 2010 Mar; 77(5):390-2. PubMed ID: 20150940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
